Navigation Links
Mylan Receives Approval for Generic Version of Flomax(R)
Date:4/28/2010

PITTSBURGH, April 28 /PRNewswire-FirstCall/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Tamsulosin Hydrochloride Capsules USP, 0.4 mg, the generic version of Boehringer Ingelheim's benign prostatic hyperplasia (BPH) treatment, Flomax®.  

Tamsulosin Hydrochloride Capsules had U.S. sales of approximately $2.2 billion for the 12 months ending Dec. 31, 2009, according to IMS Health. Mylan has started shipping this product.

Currently, Mylan has 139 ANDAs pending FDA approval representing $96.2 billion in annual brand sales, according to IMS Health. Thirty-seven of these pending ANDAs are potential first-to-file opportunities, representing $19.6 billion in annual brand sales, for the 12 months ending Dec. 31, 2009, according to IMS Health.

Mylan Inc. ranks among the leading generic and specialty pharmaceutical companies in the world and provides products to customers in more than 140 countries and territories. The company maintains one of the industry's broadest and highest quality product portfolios supported by a robust product pipeline; operates one of the world's largest active pharmaceutical ingredient manufacturers; and runs a specialty business focused on respiratory, allergy and psychiatric therapies. For more information, please visit

SOURCE Mylan Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Mylan Announces Settlement Agreement Related to Antidepressant Effexor XR(R)
2. Mylan Receives FDA Approval for Generic Version of Parkinsons Treatment Sinemet(R)
3. Mylan Schedules Third Quarter 2009 Financial Results Conference Call and Live Webcast
4. Mylan Receives FDA Approval for Generic Version of Anticonvulsant Topamax(R) Sprinkle Capsules
5. Mylan Confirms First-to-File Patent Challenge Relating to Caduet(R)
6. Mylan Receives Approval for Generic Version of GoLytely(R)
7. Mylan Declares Quarterly Preferred Stock Dividend
8. Mylan Pre-Pays All Scheduled 2011 Term-Loan Borrowings
9. Mylan Confirms First-to-File Patent Challenge Relating to Vytorin(R) Cholesterol Medication
10. Mylans President of Europe, Middle East and Africa Elected President of European Generic Medicines Association
11. Mylan Receives Tentative FDA Approval Under PEPFAR for Matrix Laboratories New Drug Application (NDA) for Efavirenz Tablets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... , March 31, 2015 ... 2015" therapeutic market research report of 68 pages ... online business intelligence library. The report ... on the therapeutic development for Pemphigus , ... assessment by drug target, mechanism of action (MoA), ...
(Date:3/31/2015)... KENNEBUNK, Maine , March 31, 2015 /PRNewswire/ ... aggregated enrollment in Medicare Advantage (MA) plans in ... approximately 17.3 million people were enrolled in Medicare ... of more than 1.3 million members year-over-year.  54.3 ... the Centers for Medicare and Medicaid Services (CMS), ...
(Date:3/31/2015)... , March 31, 2015  SynCardia Systems, Inc. has ... (IDE) clinical study on the effective use of its ... The FDA approval will ... as 30 heart failure patients. Patients enrolled in this ... as a bridge to a donor heart transplant. ...
Breaking Medicine Technology:Pemphigus Therapeutic Development and Pipeline Review H1 2015 2Pemphigus Therapeutic Development and Pipeline Review H1 2015 3Pemphigus Therapeutic Development and Pipeline Review H1 2015 4Medicare Advantage Enrollment Reaches 17 Million According to Mark Farrah Associates 2FDA Approves Investigational Study for New Smaller SynCardia Total Artificial Heart 2FDA Approves Investigational Study for New Smaller SynCardia Total Artificial Heart 3FDA Approves Investigational Study for New Smaller SynCardia Total Artificial Heart 4
(Date:3/31/2015)... Azilen Technologies adds yet ... Product Development Company’ award at GESIA 2015. The firm ... 8th Annual Award GESIA 2015. This marks Azilen’s second ... category. It previously won the ‘Best Product Innovation’ award ... in product development, enterprise mobility solutions and open source ...
(Date:3/31/2015)... Nashville, TN (PRWEB) March 31, 2015 ... availability of Dragon® Medical Practice Edition 2, allowing them ... for medical practices with 24 physicians or less. Dragon ... time required to create quality patient records. , ... best technology solutions to our clients. Our goal has ...
(Date:3/31/2015)... 31, 2015 Horizon Blue Cross Blue ... its efforts to combat health insurance fraud resulted in ... of monies recovered and losses avoided -- in 2014. ... Horizon BCBSNJ created its fraud fighting, Special Investigations Unit ... efforts have saved members $261 million. , “Our ...
(Date:3/31/2015)... (PRWEB) March 31, 2015 Juvent Sports ... the 2015 PGA Merchandise show in Orlando. At the ... Tour player Maggie Will was interviewed and she shared ... been experiencing since she began integrating the Juvent Pro ... Juvent has been so instrumental to her chronic back ...
(Date:3/31/2015)... March 31, 2015 Over the last ... Shallow Water Blackout and conducted a survey to learn ... community. , For additional information about Shallow Water Blackout ... . To read the educational articles please go to ... yielded many useful comments and personal stories about people’s ...
Breaking Medicine News(10 mins):Health News:Azilen Technologies Receives ‘Best Product Development Company’ Award at GESIA 2015 2Health News:Medical Technology Solutions of America Announces Availability of Dragon® Medical Practice Edition 2 for Medical Professionals 2Health News:Horizon Blue Cross Blue Shield of New Jersey Saves Members, Health System a Record $45.4 Million through Anti-fraud Efforts 2Health News:Former LPGA Tour Winner Maggie Will Discovers The Juvent Micro-Impact Platform as a Pain Relief Breakthrough and Performance Enhancer 2Health News:Former LPGA Tour Winner Maggie Will Discovers The Juvent Micro-Impact Platform as a Pain Relief Breakthrough and Performance Enhancer 3
... Nursing Home, Assisted Living, Home Care and Adult Day Health ... April 30 The cost of long term ... putting significant financial pressure on those in or near retirement, ... the same time, the current economic downturn has led to ...
... to Nursing Home, Assisted Living, Home Care and Adult Day ... April 30 The cost of ... outpacing inflation, putting significant financial pressure on those in or ... At the same time, the current economic downturn has ...
... formulation, egg-based production system are biggest challenges, experts say , , ... a possible swine flu pandemic, U.S. health officials are already ... swine flu vaccine. , And even though experts say there,s ... to develop -- would work, many agree it,s the logical ...
... Nursing Home, Assisted Living, Home Care and Adult Day Health ... 30 The cost of long ... outpacing inflation, putting significant financial pressure on those in or ... At the same time, the current economic downturn has led ...
... Nebraskans Access to Nursing Home, Assisted Living, Home Care and ... StatewideRICHMOND, Va., April 30 The cost of long term ... putting significant financial pressure on those in or near retirement, ... the same time, the current economic downturn has led to ...
... April 30 /PRNewswire-Asia-FirstCall/ -- China Pharma,Holdings, Inc. ("China ... markets specialty pharmaceutical products in China, today,announced that ... Financial Officer,and has nominated Ms. Heung Mei Tsui ... Mr. Frank Waung brings to China ...
Cached Medicine News:Health News:Growth in Wyoming Long Term Care Costs Outpacing the Rate of Inflation, According to Annual Genworth Financial Study 2Health News:Growth in Wyoming Long Term Care Costs Outpacing the Rate of Inflation, According to Annual Genworth Financial Study 3Health News:Growth in Wyoming Long Term Care Costs Outpacing the Rate of Inflation, According to Annual Genworth Financial Study 4Health News:Growth in Texas Long Term Care Costs Outpacing the Rate of Inflation, According to Annual Genworth Financial Study 2Health News:Growth in Texas Long Term Care Costs Outpacing the Rate of Inflation, According to Annual Genworth Financial Study 3Health News:Growth in Texas Long Term Care Costs Outpacing the Rate of Inflation, According to Annual Genworth Financial Study 4Health News:Swine Flu Vaccine Still Months Away 2Health News:Swine Flu Vaccine Still Months Away 3Health News:Growth in North Carolina Long Term Care Costs Outpacing the Rate of Inflation, According to Annual Genworth Financial Study 2Health News:Growth in North Carolina Long Term Care Costs Outpacing the Rate of Inflation, According to Annual Genworth Financial Study 3Health News:Growth in North Carolina Long Term Care Costs Outpacing the Rate of Inflation, According to Annual Genworth Financial Study 4Health News:Growth in North Carolina Long Term Care Costs Outpacing the Rate of Inflation, According to Annual Genworth Financial Study 5Health News:Growth in Nebraska Long Term Care Costs Outpacing the Rate of Inflation, According to Annual Genworth Financial Study 2Health News:Growth in Nebraska Long Term Care Costs Outpacing the Rate of Inflation, According to Annual Genworth Financial Study 3Health News:Growth in Nebraska Long Term Care Costs Outpacing the Rate of Inflation, According to Annual Genworth Financial Study 4Health News:China Pharma Holdings, Inc. Appoints Chief Financial Officer and Board Member 2Health News:China Pharma Holdings, Inc. Appoints Chief Financial Officer and Board Member 3
... Evaluating pupil response and eye movement is ... exams. Thats because eye movements and pupil ... set of visual neuronal centers and pathways ... The VisPath Analyzer (VPA) provides pre-programmed visual ...
... has developed the DigiCat Imager ("DCI") to ... of cataracts. The DCI can measure the ... so an objective, appropriate and timely surgical ... that this technology is especially useful in ...
The new Riata® i lead family allows physicians even more versatility when managing patients with high defibrillation thresholds (DFTs)....
... BrainLAB combines ease of use ... to offer an image guided system ... the surgeons individual needs. With a ... base of more than 500 physicians, ...
Medicine Products: